Keyphrases
Pulmonary Hypertension
100%
N-terminal Pro-brain Natriuretic Peptide (NT-proBNP)
77%
Bronchopulmonary Dysplasia
75%
Preterm Infants
75%
Cyanosis
75%
Procoagulant Activity
66%
Echocardiogram
63%
Hemophilia
52%
Hemodynamically Significant Patent Ductus Arteriosus
50%
Cyanotic Newborn
50%
Hartford
50%
Arginine
50%
Cysteine
50%
Light Chain
49%
Neonate
33%
Thrombin Cleavage
27%
Cleavage Site
27%
Cardiac Toxicity
25%
Premature Infant
25%
Unroofed Coronary Sinus
25%
Ventricular Septal Defect Closure
25%
Factor VIII Antibodies
25%
Magnesium Sulfate
25%
Urinary NT-proBNP
25%
High-sensitivity Troponin T
25%
Systematic Lupus Erythematosus
25%
Absent Aortic Valve
25%
Echocardiographic Parameters
25%
Sulphate Exposure
25%
Cyanotic Congenital Heart Disease
25%
Antenatal Magnesium Sulfate
25%
Cyclobenzaprine
25%
Part 2A
25%
Surrogate Biomarkers
25%
Unusual Presentation
25%
Non-invasive Biomarkers
25%
Site-directed mutation
25%
Lopinavir
25%
Persistent Pulmonary Hypertension
25%
Early Screening
25%
Hemophilia Patients
25%
Neonatologist
25%
Prenatal Diagnosis
25%
Preterm Neonates
25%
Twin Pregnancy
25%
Transthoracic Echocardiography
25%
Hypoplastic Left Heart Syndrome
25%
Infective Endocarditis
25%
Cysteamine
25%
Histocompatibility Antigens
25%
Medicine and Dentistry
Pulmonary Hypertension
100%
Echocardiography
76%
Lung Dysplasia
75%
Cyanosis
75%
Patent Ductus Arteriosus
54%
Brain Natriuretic Peptide
50%
Biological Marker
50%
Neonatal Infant
50%
Prematurity
50%
Amino Terminal Sequence
45%
Neonate
33%
Newborn Period
25%
Urinary System
25%
Troponin T
25%
Sildenafil
25%
Lopinavir/Ritonavir
25%
Cyanotic Heart Defect
25%
Twin Pregnancy
25%
Coronary Sinus
25%
Transthoracic Echocardiography
25%
Infective Endocarditis
25%
Magnesium Sulfate
25%
Ventricular Septal Defect
25%
Atrioventricular Block
25%
Cyclobenzaprine
25%
Persistent Fetal Circulation
25%
Prenatal Diagnosis
25%
Aortic Valve
25%
Hypoplastic Left Heart Syndrome
25%
Blood Clotting Factor 8
25%
Histocompatibility Antigen
25%
Cardiotoxicity
25%
Symptomatic Treatment
25%
Lupus Vulgaris
25%
Third-Degree Atrioventricular Block
20%
Persistent Truncus Arteriosus
19%
Haemophilia A
18%
Pulse Oximetry
17%
Atrial Septal Defect
16%
Gestational Age
15%
Pregnancy
15%
Diagnosis
14%
Physical Examination
14%
Infusion
12%
Hyperoxia
12%
Pathophysiology
12%
Thorax Radiography
12%
Dermatological Agent
12%
Heart Injury
12%
Heart Block
12%
Pharmacology, Toxicology and Pharmaceutical Science
Patent Ductus Arteriosus
54%
Biological Marker
50%
Pulmonary Hypertension
50%
Cysteine
50%
Procoagulant
50%
Arginine
50%
Prematurity
50%
Blood Clotting Factor 8
50%
Brain Natriuretic Peptide
30%
Thrombin
28%
Lung Dysplasia
25%
Lopinavir Plus Ritonavir
25%
Troponin T
25%
Magnesium Sulfate
25%
Cyanosis
25%
Cyclobenzaprine
25%
Von Willebrand Factor
25%
Persistent Pulmonary Hypertension
25%
Cysteamine
25%
Cardiotoxicity
25%
Complete Heart Block
8%
Proteinase Inhibitor
8%
Human Immunodeficiency Virus Infection
8%
Congestive Cardiomyopathy
8%
Iodoacetamide
5%
Prospective Cohort Study
5%
Neuroprotective Agent
5%
Calcium Channel
5%
Hemoglobin F
5%
Congenital Heart Disease
5%